25 7月 2018 by admin in UncategorizedComments resTORbio Announces Positive Topline Results in Phase 2b Trial of RTB101
11 7月 2018 by admin in UncategorizedComments resTORbio Announces Science Translational Medicine Publication of Phase 2a Data Showing Improvement in Immune Function and Decreased Infection Rates in People Aged 65 Years and Older
10 7月 2018 by admin in UncategorizedComments Syros to Host Key Opinion Leader Symposium on Acute Myeloid Leukemia and Myelodysplastic Syndrome on July 17, 2018
26 6月 2018 by admin in UncategorizedComments Centrexion Therapeutics Appoints Veteran Healthcare Innovator Joseph R. Swedish to its Board of Directors
21 6月 2018 by admin in UncategorizedComments Crescendo Biologics Appoints Clinical Development Expert, Dr Igor Matushansky, as Non-Executive Director
14 6月 2018 by admin in UncategorizedComments Syros Announces Appointment of Michael W. Bonney to Its Board of Directors
13 6月 2018 by admin in UncategorizedComments Crescendo Biologics Appoints Eva-Lotta Allan as Non-Executive Director
12 6月 2018 by admin in UncategorizedComments resTORbio Announces Appointment of Kerry Russell, M.D., Ph.D., as Vice President of Clinical Development
31 5月 2018 by admin in UncategorizedComments Zai Lab and Crescendo Biologics Enter Exclusive Worldwide License Agreement for Innovative Protein Therapeutics for Inflammatory Indications
